The 18F-choline PET-CT (FCH) has better performance in the assessment of patients with prostate cancer than 18F-FDG.
However, similarly, it is also not a tumor specific radiotracer. We present four 18F-FCH PET-CT scans in which false positive findings were correctly assessed after evaluation with CT, clinical parameters and/or histological analysis.
Written by:
García Vicente AM, Núñez García A, Soriano Castrejón AM, Jiménez Londoño GA, Cordero García JM, Palomar Muñoz A. Are you the author?
Servicio de Medicina Nuclear, Hospital General Universitario de Ciudad Real, Ciudad Real, España.
Reference: Rev Esp Med Nucl Imagen Mol. 2012 Mar 27. Epub ahead of print.
doi: 10.1016/j.remn.2012.01.005
PubMed Abstract
PMID: 23177342
Article in Spanish.
Go "Beyond the Abstract" - Read an Article Written by the Authors for UroToday.com
UroToday.com Prostate Cancer Section
